Antiplatelet drugs in the secondary prevention of stroke: differential efficacy in large versus small vessel disease? A subgroup analysis from ESPS-2.

M.J. Ariesen; A. Algra; L.J. Kappelle

Antiplatelet drugs in the secondary prevention of stroke: differential efficacy in large versus small vessel disease? A subgroup analysis from ESPS-2.

Translated title of the contribution: Antiplatelet drugs in the secondary prevention of stroke: differential efficacy in large versus small vessel disease? A subgroup analysis from ESPS-2.

M.J. Ariesen
, A. Algra
, L.J. Kappelle

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Antiplatelet drugs in the secondary prevention of stroke: differential efficacy in large versus small vessel disease? A subgroup analysis from ESPS-2.
Original language	Undefined/Unknown
Pages (from-to)	134-138
Number of pages	5
Journal	Stroke
Volume	37
Issue number	1
Publication status	Published - 2006

Cite this

@article{67cc52ef9b7b4e96bdfcbd9a1778bf38,

title = "Antiplatelet drugs in the secondary prevention of stroke: differential efficacy in large versus small vessel disease? A subgroup analysis from ESPS-2.",

author = "M.J. Ariesen and A. Algra and L.J. Kappelle",

year = "2006",

language = "Undefined/Unknown",

volume = "37",

pages = "134--138",

journal = "Stroke",

issn = "0039-2499",

publisher = "Wolters Kluwer Health",

number = "1",

}